Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications

ABSTRACT Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) is etiologically linked to primary effusion lymphoma (PEL), an aggressive and nontreatable malignancy commonly found in AIDS patients. In this study, we performed a high-throughput screening of 3,731 characterized compounds and identi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marion Gruffaz, Shenghua Zhou, Karthik Vasan, Teresa Rushing, Qing Liu Michael, Chu Lu, Jae U. Jung, Shou-Jiang Gao
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2018
Materias:	cytarabine DNA/RNA syntheses inhibition of latent and lytic replication KSHV latency-associated nuclear antigen (LANA) degradation primary effusion lymphoma Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/813532cf3c73482aa2786bdbec28fc9f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications

Ejemplares similares